Abnormalities of sexual development causing infertility in horses have been investigated since the early 1970's. Conventional cytogenetic analysis by karyotyping has been the primary tool used to investigate these horses. Abnormalities have a broad range, from a phenotypically normal mare with gonadal dysgenesis to a horse with ambiguous external genitalia and internal male and female organs. Cytogenetic analysis can determine genetic sex but cannot identify mutations or deletions of genes involved in the sex determination pathway. Molecular technologies have been developed to confirm cytogenetic results and to aid in identifying the genetic causes of abnormal sex determination in horses. In this paper, we review the historical development of methods used to understand abnormal sexual development in the horse as well as summarize cases reported over the last 40-50 years.

1.
Abe S, Miyake YI, Kageyama SI, Watanabe G, Taya K, Kawakura K: Deletion of the SRY region on the Y chromosome detected in a case of equine gonadal hypoplasia (XY female) with abnormal hormonal profiles. Equine Vet J 31:336-338 (1999).
2.
Androulakakis PA: Intersex: abnormal sexual differentiation. Arch Hell Med 16:452-456 (1999).
3.
Balsamo A, Baldazzi L, Menabò S, Cicognani A: Impact of molecular genetics on congenital adrenal hyperplasia management. Sex Dev 4:233-248 (2010).
4.
Bannasch D, Rinaldo C, Millon L, Latson K, Spangler T, et al: SRY negative 64,XX intersex phenotype in an American saddlebred horse. Vet J 173:437-439 (2007).
5.
Bleul U, Theiss F, Rutten M, Kahn W: Clinical, cytogenetic and hormonal findings in a stallion with hypospadias-a case report. Vet J 173:679-682 (2007).
6.
Bouters R, Vandeplassche M, De Moor A: An intersex (male pseudohermaphrodite) horse with 64xx/XXY mosaicism. J Reprod Fertil Suppl:375-376 (1975).
7.
Bowling AT, Millon L, Hughes JP: An update of chromosomal abnormalities in mares. J Reprod Fertil Suppl 35:149-155 (1987).
8.
Breen M, Langford CF, Carter NP, Fischer PE, Marti E, et al: Detection of equine X chromosome abnormalities in equids using a horse X whole chromosome paint probe (WCPP). Vet J 153:235-238 (1997).
9.
Bruère AN, Blue MG, Jaine PM, Walker KS, Henderson LM, Chapman HM: Preliminary observations on the occurrence of the equine XO syndrome. N Z Vet J 26:145-146 (1978).
10.
Bugno M, Klukowska J, Slota E, Tischner M, Switoński M: A sporadic case of the sex-reversed mare (64,XY; SRY-negative): molecular and cytogenetic studies of the Y chromosome. Theriogenology 59:1597-1603 (2003).
11.
Bugno M, Slota E, Kościelny M: Karyotype evaluation among young horse populations in Poland. Schweiz Arch Tierheilkd 149:227-232 (2007).
12.
Bugno M, Zabek T, Golonka P, Pieńkowska-Schelling A, Schelling C, Slota E: A case of an intersex horse with 63,X/64,XX/65,XX,del(Y)(q?) karyotype. Cytogenet Genome Res 120:123-126 (2008).
13.
Bugno M, Slota E, Pieńkowska-Schelling A, Schelling C: Identification of chromosome abnormalities in the horse using a panel of chromosome-specific painting probes generated by microdissection. Acta Vet Hung 57:369-381 (2009).
14.
Buoen LC, Zhang TQ, Ruth GR, Weber AF, Kittleson SL: Sterility associated with an XO karyotype in a miniature horse mare. Equine Vet J 25:164-165 (1993).
15.
Buoen LC, Zhang TQ, Weber AF, Ruth GR: SRY-negative, XX intersex horses: the need for pedigree studies to examine the mode of inheritance of the condition. Equine Vet J 32:78-81 (2000).
16.
Cadario ME: Case notes and commentary: XY sex reversal in mares: testicular feminization or gonadal/ovarian dysgenesis? Comp Cont Educ Pract 23:753-759 (2001).
17.
Constant SB, Larsen RE, Asbury AC, Buoen LC, Mayo M: XX male syndrome in a cryptorchid stallion. J Am Vet Med Assoc 205:83-85 (1994).
18.
De Lorenzi L, Genualdo V, Iannuzzi A, Di Meo GP, Perucatti A, et al: Cytogenetic and genetic studies in a hypospadic horse (Equus caballus, 2n = 64). Sex Dev 4:352-357 (2010).
19.
Durkin KW, Raudsepp T, Chowdhary BP: Cytogenetic evaluation of the stallion, in McKinnon AO, Squires EL, Vaala WE, Varner DD (eds): Equine Reproduction, pp 1462-1468 (Wiley Blackwell, Oxford 2011).
20.
Evans HE, Sack WO: Prenatal development of domestic and laboratory mammals: growth curves, external features and selected references. Zentralbl Vetrinarmed C 2:11-45 (1973).
21.
Finley B: Another sex dispute, but this athlete has four legs. New York Times, 2009.
22.
Fretz PB, Hare WC: A male pseudohermaph-rodite horse with 63XO?/64XX/65XXY mixoploidy. Equine Vet J 8:130-132 (1976).
23.
Fukami M, Wada Y, Miyabayashi K, Nishino I, Hasegawa T, et al: CXORF6 is a causative gene for hypospadias. Nat Genet 38:1369-1371 (2006).
24.
Halnan CR: Equine cytogenetics: role in equine veterinary practice. Equine Vet J 17:173-177 (1985).
25.
Hasegawa T, Ishida M, Harigaya T, Sato F, Ishida N, Mukoyama H: Linear SRY transcript in equine testis. J Vet Med Sci 61:97-100 (1999).
26.
Hasegawa T, Sato F, Ishida N, Fukushima Y, Mukoyama H: Sex determination by simultaneous amplification of equine SRY and amelogenin genes. J Vet Med Sci 62:1109-1110 (2000).
27.
Herzog A, Höhn H, Hecht WC: A 63,XO/64,XYY t(Y;Y) mosaic in a foal. Proc of the 8th Eur Colloq Cytogenet Domest Anim, Bristol, 1988, pp 60-65.
28.
Hirota K, Piumi F, Sato F, Ishida N, Guérin G, et al: FISH assignment of two equine BAC clones containing SRY and ZFY. Anim Genet 32:326-327 (2001).
29.
Höhn H, Klug E, Rieck GW: A 63,XO/65,XYY mosaic in a case of questionable equine male pseudohermaphroditism. Proc of the 4th Eur Colloq Cytogenet Domest Anim, Uppsala, 1980, pp 82-92.
30.
Howden KJ: Androgen insensitivity syndrome in a thoroughbred mare (64, XY-testicular feminization). Can Vet J 45:501-503 (2004).
31.
Hughes JP, Benirschke K, Kennedy PC, Trommershausen-Smith A: Gonadal dysgenesis in the mare. J Reprod Fertil Suppl:385-390 (1975).
32.
Jacobs P, Dalton P, James R, Mosse K, Power M, et al: Turner syndrome: a cytogenetic and molecular study. Ann Hum Genet 61:471-483 (1997).
33.
Jaszczak K: SRY-negative, 64,XX sex reversal in a Konik Polski horse: a case report. Anim Sci P 28:381-388 (2010).
34.
Jones KL, Smith DW: Smith's recognizable patterns of human malformation, ed 6, (Elsevier Saunders, Philadelphia 2006).
35.
Kakoi H, Hirota K, Gawahara H, Kurosawa M, Kuwajima M: Genetic diagnosis of sex chromosome aberrations in horses based on parentage test by microsatellite DNA and analysis of X- and Y-linked markers. Equine Vet J 37:143-147 (2005).
36.
Kent MG, Shoffner RN, Buoen L, Weber AF: XY sex-reversal syndrome in the domestic horse. Cytogenet Cell Genet 42:8-18 (1986).
37.
Kent MG, Shoffner RN, Hunter A, Elliston KO, Schroder W, et al: XY sex reversal syndrome in the mare: clinical and behavioral studies, H-Y phenotype. Hum Genet 79:321-328 (1988).
38.
Lear TL, Bailey E: Equine clinical cytogenetics: the past and future. Cytogenet Genome Res 120:42-49 (2008).
39.
Mäkelä O, Gustavsson I, Hollmén T: A 64,X,i(Xq) karyotype in a standardbred filly. Equine Vet J 26:251-254 (1994).
40.
Mäkinen A, Hasegawa T, Mäkilä M, Katila T: Infertility in two mares with XY and xxx sex chromosomes. Equine Vet J 31:346-349 (1999).
41.
Mäkinen A, Katila T, Andersson M, Gustavsson I: Two sterile stallions with XXY-syndrome. Equine Vet J 32:358-360 (2000).
42.
Mäkinen A, Suojala L, Niini T, Katila T, Tozaki T, et al: X chromosome detection in an XO mare using a human X paint probe, and PCR detection of SRY and amelogenin genes in 3 XY mares. Equine Vet J 33:527-530 (2001).
43.
Melsky R: Pacer arizona helen reclassified as ‘horse'. http://www.thehorse.com/ViewArticle.aspx?ID=14677.
44.
Meyers-Wallen VN, Hurtgen J, Schlafer D, Tulleners E, Cleland WR, et al: SRY-negative XX true hermaphroditism in a Pasa Fino horse. Equine Vet J 29:404-408 (1997).
45.
Milliken JE, Paccamonti DL, Shoemaker S, Green WH: XX male pseudohermaphroditism in a horse. J Am Vet Med Assoc 207:77-79 (1995).
46.
Nie G, Momont HW, Buoen L: A survey of sex chromosome abnormalities in 204 mares selected for breeding. J Equine Vet Sci 13:456-459 (1993).
47.
Paget S, Ducos A, Mignotte F, Raymond I, Pinton A, et al: 63,XO/65,XYY mosaicism in a case of equine male pseudohermaphroditism. Vet Rec 148:24-25 (2001).
48.
Pailhoux E, Cribiu EP, Parma P, Cotinot C: Molecular analysis of an XY mare with gonadal dysgenesis. Hereditas 122:109-112 (1995).
49.
Paria N, Raudsepp T, Pearks Wilkerson AG, O'Brien PC, Ferguson-Smith MA, et al: A gene catalogue of the euchromatic male-specific region of the horse Y chromsome: comparison with human and other mammals. PloS One 6:e21374 (2011).
50.
Power MM: XY sex reversal in a mare. Equine Vet J 18:233-236 (1986).
51.
Power MM: Equine half sibs with an unbalanced X;15 translocation or trisomy 28. Cytogenet Cell Genet 45:163-168 (1987).
52.
Power MM: Chromosomes of the horse, in McFeely RA (ed): Advances in Veterinary Science and Comparative Medicine, Domestic Animal Cytogenetics, Vol 34, pp 131-167 (Academic Press, San Diego 1990).
53.
Raudsepp T, Lee EJ, Kata SR, Brinkmeyer C, Mickelson JR, et al: Exceptional conservation of horse-human gene order on X chromosome revealed by high-resolution radiation hybrid mapping. Proc Natl Acad Sci USA 101:2386-2391 (2004a).
54.
Raudsepp T, Santani A, Wallner B, Kata SR, Ren C, et al: A detailed physical map of the horse Y chromosome. Proc Natl Acad Sci USA 101:9321-9326 (2004b).
55.
Raudsepp T, Durkin K, Lear TL, Das PJ, Avila F, et al: Molecular heterogeneity of XY sex reversal in horses. Anim Genet 41 Suppl 2:41-52 (2010).
56.
Reid SW, Weatherston JF, Robinson BN: X chromosome mosaicism and infertility in a mare. Can Vet J 28:533-534 (1987).
57.
Röder P: Hypospadie beim Pferd [German]. Berl Tierärztl Wochenschr 47:797-798 (1929).
58.
Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, et al: The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423:825-837 (2003).
59.
Sutherland RW, Wiener JS, Hicks JP, Marcelli M, Gonzales ET Jr: Androgen receptor gene mutations are rarely associated with isolated penile hypospadias. J Urol 156:828-831 (1996).
60.
Switonski M, Chmurzynska A, Szczerbal I, Lipczynski A, Yang F, Nowicka-Posluszna A: Sex reversal syndrome (64,XY; SRY-positive) in a mare demonstrating masculine behaviour. J Anim Breed Genet 122 Suppl 1:60-63 (2005).
61.
Vaughan L, Schofield W, Ennis S: SRY-negative XX sex reversal in a pony: a case report. Theriogenology 55:1051-1057 (2001).
62.
Villagómez DA, Parma P, Radi O, Di Meo G, Pinton A, et al: Classical and molecular cytogenetics of disorders of sex development in domestic animals. Cytogenet Genome Res 126:110-131 (2009).
63.
Villagómez DA, Lear TL, Chenier T, Lee S, McGee RB, et al: Equine disorders of sexual development in 17 mares including XX, SRY-negative, XY, SRY-negative and XY, SRY-positive genotypes. Sex Dev 5:16-25 (2011).
64.
Zinn AR, Ross JL: Molecular analysis of genes on Xp controlling turner syndrome and premature ovarian failure (POF). Semin Reprod Med 19:141-146 (2001).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.